High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean lung liquid versus invasive biopsy program

Cancer ◽  
2021 ◽  
Author(s):  
Sehhoon Park ◽  
Steve Olsen ◽  
Bo Mi Ku ◽  
Min‐Sang Lee ◽  
Hyun‐Ae Jung ◽  
...  
2020 ◽  
Author(s):  
Luiz H Araujo ◽  
Carlos Gil Ferreira ◽  
Clarissa S Baldotto ◽  
Clarissa Mathias ◽  
Gilberto Castro ◽  
...  

The objective of this review is to address the barriers limiting access to next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) for metastatic nonsquamous non-small cell lung cancer in Brazil and to propose its implementation in practice. A selected panel of lung cancer experts was provided with relevant prompts to address at a conference; a paper was then compiled on the topic. The authors propose specific and realistic recommendations for implementing access to ctDNA NGS. Further, the authors address all barriers and impediments mentioned within this review. There is a great need to increase ctDNA NGS for cancer care in Brazil. Adapting the current cancer testing framework is essential to expanding the use of this tool.


2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e23021-e23021 ◽  
Author(s):  
Stephen R Fairclough ◽  
Oliver A. Zill ◽  
Darya Chudova ◽  
Christine Elaine Lee ◽  
Richard Burnham Lanman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document